Modulation of myofascial pain by the reproductive hormones: A preliminary report

被引:75
作者
Dao, TTT [1 ]
Knight, K [1 ]
Ton-That, V [1 ]
机构
[1] Univ Toronto, Fac Dent, Dept Stat, Toronto, ON M5G 1G6, Canada
关键词
D O I
10.1016/S0022-3913(98)70073-3
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Statement of problem. The predominance of myofascial pain in women in childbearing years suggests that the reproductive hormones may play a role in this pain disorder. Purpose, The potential influence of these hormones on myofascial pain was evaluated. Methods. Pain patterns were compared across three consecutive menstrual cycles in oral contraceptives users (OC group) and nonusers (Non-OC group). Results. Preliminary results showed that within menstrual cycle variability of daily pain was higher than the nonusers group. In addition to their low variation, pain levels of oral contraceptives users remained positive across the hormonal cycle, whereas in nonusers, peaks of pain alternated frequently with pain-free periods. These data suggest that pain levels in oral contraceptives users may be more constant than those of nonusers. Conclusions. This potential hormonal influence on myofascial pain levels among oral contraceptives users may represent one of the various adverse effects induced by oral contraceptives at the trigeminal area in sensitive subjects. Evidence supporting the link between estrogen, nitric oxide, and inflammatory processes is presented.
引用
收藏
页码:663 / 670
页数:8
相关论文
共 76 条
[1]  
AMBJORNSSON E, 1983, ACTA CHIR SCAND, V149, P603
[2]   PERIODONTAL STATUS DURING PREGNANCY [J].
ARAFAT, AH .
JOURNAL OF PERIODONTOLOGY, 1974, 45 (08) :641-643
[3]   ESTROGEN-RECEPTORS IN THE TEMPOROMANDIBULAR-JOINT OF THE BABOON (PAPIO-CYNOCEPHALUS) - AN AUTORADIOGRAPHIC STUDY [J].
AUFDEMORTE, TB ;
VANSICKELS, JE ;
DOLWICK, MF ;
SHERIDAN, PJ ;
HOLT, GR ;
ARAGON, SB ;
GATES, GA .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1986, 61 (04) :307-314
[4]   EVALUATION OF CLINICAL RESPONSE TO PIPERAZINE OESTRONE SULPHATE (HARMOGEN) IN MENOPAUSAL PATIENTS [J].
AYLWARD, M ;
HOLLY, F ;
PARKER, RJ .
CURRENT MEDICAL RESEARCH AND OPINION, 1974, 2 (07) :417-423
[5]   THE COMBINED ORAL-CONTRACEPTIVE - RISKS AND ADVERSE-EFFECTS IN PERSPECTIVE [J].
BAGSHAW, S .
DRUG SAFETY, 1995, 12 (02) :91-96
[6]   CHANGES IN SKIN BLOOD-FLOW DURING THE MENSTRUAL-CYCLE - THE INFLUENCE OF THE MENSTRUAL-CYCLE ON THE PERIPHERAL-CIRCULATION IN HEALTHY FEMALE VOLUNTEERS [J].
BARTELINK, ML ;
WOLLERSHEIM, H ;
THEEUWES, A ;
VANDUREN, D ;
THIEN, T .
CLINICAL SCIENCE, 1990, 78 (05) :527-532
[7]   EFFECTS OF PROGESTERONE ON PROLACTIN, HYPOTHALAMIC BETA-ENDORPHIN, HYPOTHALAMIC SUBSTANCE-P, AND MIDBRAIN SEROTONIN IN GUINEA-PIGS [J].
BETHEA, CL ;
HESS, DL ;
WIDMANN, AA ;
HENNINGFELD, JM .
NEUROENDOCRINOLOGY, 1995, 61 (06) :695-703
[8]  
BICKERSTAFF ER, 1975, NEUROLOGICAL COMPLIC
[9]   Differential effects of low- and high-dose estrogen treatments on vascular responses in female rats [J].
Bolego, C ;
Cignarella, A ;
Ruzza, R ;
Zaarour, C ;
Messi, E ;
Zanisi, M ;
Puglisi, L .
LIFE SCIENCES, 1997, 60 (25) :2291-2302
[10]   INCREASED RISK OF INFLAMMATORY BOWEL-DISEASE ASSOCIATED WITH ORAL-CONTRACEPTIVE USE [J].
BOYKO, EJ ;
THEIS, MK ;
VAUGHAN, TL ;
NICOLBLADES, B .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (03) :268-278